Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
As many readers will be aware, there has been a recent and increasing focus on whether abnormal pathological findings on biopsy classified as Gleason grade 3 + 3 = 6 should really be classified as “cancer” at all. This also has major implications for its management.
Filed under: Diagnosis, Management, Risk | Tagged: description, ethics, low risk, Management, Treatment | 14 Comments »
One of the problems with prostate cancer is that it can take many years for the disease to develop from a very small group of cells in a man’s prostate into a disorder that has actual clinical significance.
Filed under: Diagnosis, Risk | Tagged: clinically significant, early stage, ethics, Malmo, prognosis, trial | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site